These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8321732)

  • 1. Oligonucleotide pharmacotherapy: an antigene strategy.
    Nagel KM; Holstad SG; Isenberg KE
    Pharmacotherapy; 1993; 13(3):177-88. PubMed ID: 8321732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Making antisense of splicing.
    Garcia-Blanco MA
    Curr Opin Mol Ther; 2005 Oct; 7(5):476-82. PubMed ID: 16248283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not nonsense but antisense--applications of antisense oligonucleotides in different fields of medicine.
    Oberbauer R
    Wien Klin Wochenschr; 1997 Jan; 109(2):40-6. PubMed ID: 9123943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense oligonucleotide derivatives as gene-targeted drugs.
    Knorre DG; Vlassov VV
    Biomed Sci; 1990 Apr; 1(4):334-43. PubMed ID: 1723003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligonucleotides as therapeutics for malignant diseases.
    Ho PT; Parkinson DR
    Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic oligonucleotides.
    Goodchild J
    Methods Mol Biol; 2011; 764():1-15. PubMed ID: 21748630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antisense oligonucleotides resistance to coxsackievirus B3 infection in HeLa cells].
    Sun H; Liu Z; Zhang T
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):295-7. PubMed ID: 11860805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antisense oligonucleotides are clinically tested. They inhibit the expression of disease-related genes].
    Sommer W; Heilig M
    Lakartidningen; 1999 Jan; 96(4):348-54. PubMed ID: 10024826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides.
    Detrick B; Nagineni CN; Grillone LR; Anderson KP; Henry SP; Hooks JJ
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):163-9. PubMed ID: 11133862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense technology and prospects for therapy of viral infections and cancer.
    Wagner RW; Flanagan WM
    Mol Med Today; 1997 Jan; 3(1):31-8. PubMed ID: 9021740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense oligonucleotide technology: from EST to therapeutics.
    Giles RV
    Curr Opin Mol Ther; 2000 Jun; 2(3):238-52. PubMed ID: 11249617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligonucleotides as antivirals: dream or realistic perspective?
    Van Aerschot A
    Antiviral Res; 2006 Sep; 71(2-3):307-16. PubMed ID: 16621039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense oligonucleotide therapy in cancer.
    Stephens AC; Rivers RP
    Curr Opin Mol Ther; 2003 Apr; 5(2):118-22. PubMed ID: 12772500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense oligonucleotide-based therapeutics for cancer.
    Dean NM; Bennett CF
    Oncogene; 2003 Dec; 22(56):9087-96. PubMed ID: 14663487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense oligonucleotide therapy in urology.
    Kausch I; Böhle A
    J Urol; 2002 Jul; 168(1):239-47. PubMed ID: 12050550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antisense oligonucleotides: a new therapeutic approach].
    Guinot P; Temsamani J
    Pathol Biol (Paris); 1998 May; 46(5):347-54. PubMed ID: 9769897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense of oligonucleotides and the inhibition of oncogene expression.
    Prins J; de Vries EG; Mulder NH
    Clin Oncol (R Coll Radiol); 1993; 5(4):245-52. PubMed ID: 8398922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of gene expression in viruses and protozoan parasites by antisense oligonucleotides.
    Toulmé JJ; Bourget C; Compagno D; Yurchenko L
    Parasitology; 1997; 114 Suppl():S45-59. PubMed ID: 9309768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical and transdermal delivery of antisense oligonucleotides.
    Brand RM
    Curr Opin Mol Ther; 2001 Jun; 3(3):244-8. PubMed ID: 11497348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antisense nucleotides for therapy].
    Wang J; Wang L; Wang Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):230-4. PubMed ID: 16532848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.